Facile conversion of racemic ibuprofen to (S)-ibuprofen

被引:19
|
作者
Chavez-Flores, David [1 ]
Salvador, James M. [1 ]
机构
[1] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA
关键词
D O I
10.1016/j.tetasy.2012.02.014
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The methyl ester of ibuprofen was quantitatively formed by Fischer esterification and converted into (S)-ibuprofen in 94% yield with an ee of 94% under dynamic kinetic resolution conditions at pH 9.8, using Candida rugosa lipase, and 20% DMSO. The (R)-methyl ibuprofen ester was observed to racemize by chiral HPLC without the Candida rugosa lipase present. The rates of in situ racemization and enzymatic hydrolysis for the dynamic kinetic resolution were determined to be 0.026 +/- 0.004 and 0.053 +/- 0.004 h(-1), respectively. The rate of enzymatic hydrolysis when no DMSO was present was twice as fast but no racemization occurred. A facile purification of enriched (S)-ibuprofen was developed. Overall, 88% of racemic ibuprofen by weight was converted into (S)-ibuprofen with an ee of 99.7%. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:237 / 239
页数:3
相关论文
共 50 条
  • [1] Isomerase activity of Candida rugosa lipase in the optimized conversion of racemic ibuprofen to (S)-ibuprofen
    Mortazavi, Saideh S.
    Chavez-Flores, David
    Salvador, James M.
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2016, 21 (05) : 634 - 640
  • [2] Isomerase activity of Candida rugosa lipase in the optimized conversion of racemic ibuprofen to (S)-ibuprofen
    Saideh S. Mortazavi
    David Chavez-Flores
    James M. Salvador
    Biotechnology and Bioprocess Engineering, 2016, 21 : 634 - 640
  • [3] GASTRIC TOLERABILITY OF S(+) IBUPROFEN COMPARED TO RACEMIC IBUPROFEN
    CULLEN, DJ
    HUDSON, N
    ATHERTON, JC
    FILIPOWICZ, B
    GASTROENTEROLOGY, 1995, 108 (04) : A78 - A78
  • [4] S(+) VERSUS RACEMIC IBUPROFEN
    KLEIN, G
    NEFF, H
    KULLICH, W
    PHLEPS, W
    KOLLENZ, CJ
    LANCET, 1992, 339 (8794): : 681 - 681
  • [5] STEREOSELECTIVE METABOLISM OF IBUPROFEN IN HUMANS - ADMINISTRATION OF R-IBUPROFEN, S-IBUPROFEN AND RACEMIC IBUPROFEN
    RUDY, AC
    KNIGHT, PM
    BRATER, DC
    HALL, SD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 259 (03): : 1133 - 1139
  • [6] Pharmacokinetics (PK) of S-ibuprofen and racemic ibuprofen.
    Maenpaa, J
    Perttunen, K
    Ikavalko, H
    Hakola, P
    Seppanen, J
    Hanski, K
    Kleimola, T
    Aranko, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 143 - 143
  • [7] Analgesic efficacy of the S(+) isomer of ibuprofen in comparison to racemic ibuprofen.
    Dionne, RA
    McCullagh, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PIII5 - PIII5
  • [8] EQUIPOTENT INHIBITION BY R(-)-IBUPROFEN, S(+)-IBUPROFEN AND RACEMIC IBUPROFEN OF HUMAN POLYMORPHONUCLEAR CELL-FUNCTION INVITRO
    VILLANUEVA, M
    HECKENBERGER, R
    STROBACH, H
    PALMER, M
    SCHROR, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 35 (03) : 235 - 242
  • [9] Effects of homochiral molecules of (S)-(+)-ibuprofen and (S)-(-)-sodium ibuprofen dihydrate on the crystallization kinetics of racemic (R,S)-(±)-sodium ibuprofen dihydrate
    Lee, Tu
    Chen, Ying Hsiu
    Wang, Yeh Wen
    CRYSTAL GROWTH & DESIGN, 2008, 8 (02) : 415 - 426
  • [10] BRUFEN - EXTENT OF ISOMERIC CONVERSION OF R(-)IBUPROFEN TO S(+)IBUPROFEN
    ROTHERHAM, NE
    BRATTY, JR
    WRIGHT, RF
    BYROM, WD
    CRAMPTON, EL
    GLASS, RC
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 152 - 152